Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Recording and Reporting In-Process Control Data – V 2.0

Posted on By

Gel Manufacturing: SOP for Recording and Reporting In-Process Control Data – V 2.0

Standard Operating Procedure for Recording and Reporting In-Process Control Data in Gel Manufacturing


Department Gel Manufacturing
SOP No. SOP/GM/080/2025
Supersedes SOP/GM/080/2022
Page No. Page 1 of 12
Issue Date 02/06/2025
Effective Date 04/06/2025
Review Date 02/06/2026

1. Purpose

To define a standardized procedure for recording and reporting in-process control (IPC) data generated during various stages of gel manufacturing to ensure traceability, accuracy, and compliance with regulatory standards.

2. Scope

This procedure applies to all personnel

involved in the gel manufacturing process where IPC tests such as pH, viscosity, appearance, weight variation, and temperature are conducted and documented.

3. Responsibilities

  • Operators: Perform IPC checks as per instructions and fill data in real-time.
  • Production Chemist: Review IPC data and ensure it is within specifications.
  • QA Personnel: Verify completeness, accuracy, and regulatory compliance of IPC records.
See also  Gel Manufacturing: SOP for Analyzing Stability Data for Gel Formulations - V 2.0

4. Accountability

Head – Manufacturing is accountable for ensuring proper documentation and timely reporting of IPC data for all gel batches.

5. Procedure

5.1 In-Process Testing Stages

  1. At various critical stages of gel production (e.g., post-mixing, post-homogenization, during filling), designated IPC parameters must be tested and recorded.
  2. Typical IPC parameters for gels include:
    • pH
    • Viscosity
    • Appearance
    • Temperature
    • Weight variation of filled tubes
    • Homogeneity

5.2 Recording IPC Data

  1. Use the approved “In-Process Control Record” format (Annexure-1).
  2. Enter results immediately after test completion to ensure real-time traceability.
  3. Include tester’s name, date, time, equipment ID, and any deviation observed.
  4. All entries must be legible, in indelible ink, and without overwriting. Corrections should be countersigned with justification.
See also  Gel Manufacturing: SOP for Maintaining Equipment Cleaning Logs - V 2.0

5.3 Review and Verification

  1. Production Chemist shall review all IPC entries within the same shift for completeness and compliance.
  2. QA shall verify critical parameters before approving batch continuation or release to the next stage.
  3. IPC results outside specifications must be escalated immediately and managed per deviation handling SOP.

5.4 Data Reporting and Archiving

  1. Summarize IPC data in the Batch Manufacturing Record (BMR).
  2. Submit completed IPC records to QA within 24 hours of batch completion.
  3. QA shall retain IPC records as part of batch documentation for a minimum of 5 years or as per regulatory requirement.

6. Abbreviations

  • IPC: In-Process Control
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure
See also  Gel Manufacturing: SOP for Visual Inspection of Gel Batches - V 2.0

7. Documents

  1. In-Process Control Record – Annexure-1
  2. Batch Manufacturing Record (BMR)

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO GMP Guidelines for In-Process Controls

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: In-Process Control Record

Date Time Batch No. Stage Parameter Observed Value Specification Checked By Remarks
pH 6.0–7.5
Viscosity 5000–10000 cP
Temperature 25±2°C
Weight Variation ±5%

Revision History

Revision Date Revision No. Change Description Reason Approved By
01/06/2022 1.0 Initial Release New SOP QA Head
02/06/2025 2.0 Detailed recording procedure and updated annexure format Compliance Update QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: API Manufacturing: SOP for Batch Number Generation and Control – V 2.0
Next Post: Biosimilars: SOP for Sampling During Night Shifts – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version